ChemAxon and Research Space are pleased to announce the development of a prototype for direct assay data upload from RSpace ELN to ChemAxon Assay. RSpace is an electronic lab notebook used to collect, organize and present life sciences research data, and is distinguished by its flexibility in supporting a variety of workflows, strong support for traceability, and […]
We are pleased to announce Schrödinger software release 2019-3, which is available for download now. This quarterly release includes usability improvements and performance enhancements across all of our software. Click here to learn more about new features in 2019-3.
CDD Vault will support Voronoi’s collaborative research on Kinase Inhibitor and TPD INCHEON, South Korea and SAN FRANCISCO, Aug. 23, 2019 /PRNewswire/ — Voronoi, a drug discovery and development biotech company in Korea announced today that it has, after an extensive evaluation process, selected CDD Vault as its platform of choice to manage its drug discovery data and collaborative projects. […]
Extended collaboration leveraging Schrödinger’s computational platform includes new terms with increased and additional milestone payments to Schrödinger NEW YORK – Schrödinger today announced an expansion of its computational design collaboration with Morphic Therapeutic (“Morphic”), a biotechnology company focused on developing a new class of oral small-molecule integrin-targeted therapeutics that Schrödinger co-founded with Harvard Professor Timothy Springer, […]
NEW YORK – Schrödinger today announced the appointment of veteran pharmaceutical executive Gary Sender to its Board of Directors, as well as his appointment as Chair of the Audit Committee. Mr. Sender brings over 30 years of financial leadership experience, with a strong track record of success. “Gary’s business and finance expertise across entrepreneurial startups and […]
NEW YORK – Schrödinger today announced receipt of a milestone payment from Ono Pharmaceutical Co., Ltd.(“Ono”) as part of a collaboration leveraging Schrödinger’s advanced computational platform to develop novel therapeutic candidates acting on the therapeutic target selected by Ono. To advance the program, Schrödinger deployed its reaction-based enumeration tools and machine-learning technologies to identify and filter millions […]
Milestone marks advancement of second drug discovery program under the collaboration NEW YORK – Schrödinger today announced receipt of a preclinical milestone payment from Sanofi in a drug discovery program advancing as part of a multi-year, multi-target collaboration between the two companies. Under the terms of the collaboration, Schrödinger provides advanced molecular simulation and computational design expertise […]
New hires to lead ADME/PK and Clinical Pharmacology for rapidly advancing internal pipeline programs NEW YORK – Schrödinger today announced an expansion of its drug discovery leadership team to strengthen its expertise in preclinical development and translational science as the company advances internal drug discovery programs powered by its physics-based molecular modeling platform. Duncan Hamish Wright, […]
We are pleased to announce Schrödinger software release 2019-2, which is available for download now. This quarterly release includes usability improvements and performance enhancements across all of our software. Click here to learn more about new features in 2019-2.
New funding to support platform advancements and proprietary pipeline expansion NEW YORK – Schrödinger today announced that several new investors have joined its latest funding round, which was completed with a total raise of $110 million to support continued advancement of the company’s industry-leading computational platform and expansion of its therapeutic pipeline. New investors include […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

